Net loss for the fourth quarter of 2025 was $ (546,856) compared to a net loss of ($1,082,935) for the quarter ended December 31, 2024. In the current quarter, a deferred tax recovery of $1,310,256 ...
Novel medicines hold promise for patients, but rising costs pose affordability and equity challenges for health systems ...
Medtronic stock: hold amid slow growth, high debt, and competition. Read here for MDT update and a look at whether it is a ...
SALT LAKE CITY, UT / ACCESS Newswire / April 23, 2026 / In the first calendar quarter (1Q) of 2026, Utah Medical Products, Inc. (Nasdaq:UTMD) attained financial results which were consistent with its ...
Consolidated Net Sales Decline of 3.3% GAAP Diluted Loss Per Share of $2.41 Adjusted Diluted EPS(1) of $0.83 Cash Flow from Operations of $111.3 Million; Free Cash Flow(1)(2) of $103.1 Million ...
The Nation on MSNOpinion
I’m a Maine Reporter Who Went to High School With Graham Platner
Here’s what explains his success. In 2002, my classmate Graham Platner ran for student-body president of John Bapst Memorial ...
APRIL 2026 at 12:00 EEST . Orion Group Interim report January–March 2026. January–March 2026 Highlights. Net sales totalled EUR ...
Artificial intelligence (AI) is no longer just a concept. promeThis is a distant prospect to become a concrete reality in ...
Less than a year after remaking a key vaccine advisory committee, US Health and Human Services Secretary Robert F. Kennedy Jr ...
The latest report from Paragon, which has targeted hospitals, relies on a long list of distorted and debunked arguments.
Anteris Technologies is developing DurAVR, a differentiated biomimetic TAVR device with encouraging early clinical data in ...
Swiss skincare firm Galderma on Thursday said first-quarter sales jumped 25.5% in constant-currency terms to $1.47 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results